| Revenue growth | Consolidated +13.2% YoY; Gurgaon +14.5% |
|---|---|
| Margins | Gurgaon ops EBITDA 21.4% (+199 bps YoY); consolidated 17.6% |
| Demand visibility | IP volume +12% YoY; occupancy 68.1%, up 398 bps |
Growth
Gurgaon revenue +14.5% YoY, ops EBITDA +26.3%, ARPOB +6.6%, IP volume +12%. H1 consolidated revenue +13.0%, PAT +22.2%.
Outlook
~2,000 beds by 2030; 110-bed Mauritius facility in FY27; 650+ bed South Delhi hospital around FY29/FY30; ~INR 700 Cr fund raise approved.
Risks
Raipur losses (~INR 872 Lacs Q2 EBITDA drag); consolidated ops margin 17.6%, down 202 bps QoQ; ~30% international patient exposure.
Last quarter's promises, checked
Delivered
- Gurgaon FY27 ops margin 20-21% → 21.4% (= BEAT)
- Analyst-cited ARPOB growth 4-5% (mgmt: 'possible') → Gurgaon ARPOB +6.6% YoY (= BEAT)
Partly delivered
- Intl patient share ~30% ('closer to, if not better than 30%') → ~30% (= PARTIAL)
- Raipur ~INR 20 Cr overall operating loss → Q2 EBITDA drag INR 8.72 Cr, period basis unclear (= PARTIAL)
Missed
- Occupancy 70% by Q2 → 68.1% (= MISS)
Investor Presentation filed with BSE, NSE: ARTEMISMED. Summary written with AI assistance from the document.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹293.20
- Market cap
- ₹4,642 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 40.8×Sector 52.3×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Other Announcement
Artemis Medicare filed CARE Ratings' quarterly monitoring report on its Rs.330 crore preferential issue. It reports no deviation, with proceeds used as per the disclosed objects.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Artemis Medicare Services Q2 FY27 Results: Net Profit ₹31.1 Cr, Up 3.7% YoY
Artemis Medicare Services Ltd reported revenue from operations of ₹311 Cr (+13.2% YoY) and net profit of ₹31.1 Cr (+3.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31.1 Cr · +3.7% YoY
Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.
Artemis Medicare Services Other Announcement
Artemis Medicare Services Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Artemis Medicare Services Legal & Regulatory
Artemis Medicare received a Rs. 11.11 Crore Show Cause Notice from the GST department. The company is contesting this through a writ petition.
- Value
- ₹11.11 Cr